DiaMedica Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
DMAC Nasdaq 8731 https://www.diamedica.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for DiaMedica Therapeutics Inc

DiaMedica Therapeutics to Report Fourth Quarter 2023 Financial Results and Provide a Business Update March 29, 2023 - Mar 20th, 2023 8:17 pm
DiaMedica Therapeutics to Present at the Oppenheimer 33rd Annual Healthcare Conference - Mar 13th, 2023 12:00 pm
DiaMedica Therapeutics Announces the Appointment of Biopharma Veteran Tanya Lewis to Its Board of Directors - Mar 6th, 2023 1:30 pm
We Think DiaMedica Therapeutics (NASDAQ:DMAC) Can Afford To Drive Business Growth - Dec 31st, 2022 1:02 pm
Insider Buying: The DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Independent Director Just Bought 38% More Shares - Dec 4th, 2022 12:04 pm
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2022 Financial Results - Nov 9th, 2022 9:15 pm
DiaMedica Therapeutics to Attend the 13th Annual Craig-Hallum Alpha Select Conference November 17, 2022 - Nov 7th, 2022 1:32 pm
What Makes DiaMedica Therapeutics, Inc. (DMAC) a New Buy Stock - Nov 2nd, 2022 4:00 pm
DiaMedica Therapeutics to Present at Credit Suisse 31st Annual Healthcare Conference - Oct 31st, 2022 12:32 pm
DiaMedica Therapeutics Provides Update on ReMEDy2 Trial - Oct 26th, 2022 8:30 pm
Insiders rewarded with a US$114k addition on top of their US$676k purchase as DiaMedica Therapeutics Inc. (NASDAQ:DMAC) hits US$41m - Oct 14th, 2022 1:49 pm
DiaMedica Therapeutics Appoints Julie Daves as SVP, Clinical Development Operations - Sep 14th, 2022 12:30 pm
DiaMedica Therapeutics to Present at Lake Street’s 6th Annual Best Ideas Growth Conference - Sep 6th, 2022 8:10 pm
DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2022 Financial Results - Aug 10th, 2022 9:20 pm
DiaMedica Therapeutics to Report Second Quarter 2022 Financial Results and Provide a Business Update August 11, 2022 - Aug 4th, 2022 12:12 pm
DiaMedica Therapeutics to Participate in the BTIG Biotechnology Conference 2022 - Aug 1st, 2022 8:32 pm
CORRECTION: Thomas Von Koch Acquires Common Shares of DiaMedica Therapeutics Inc. - Jul 21st, 2022 8:31 pm
Thomas Von Koch Acquires Common Shares of DiaMedica Therapeutics Inc. - Jul 21st, 2022 7:50 pm
We're Not Very Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Rate - Jul 14th, 2022 11:05 am
FDA Institutes Clinical Hold On DiaMedica's Late-Stage Stroke Trial - Read Why - Jul 7th, 2022 11:37 am